Our staff remains available to you 24/7, offering safe and contactless client services by phone, email and video conference. Learn More!

FDA Updates Warning Label for Fluoroquinolones

Doctors have known about the serious side effects associated with Fluoroquinolones like Cipro, including tendon ruptures and neurological issues, for a number of years. In response, prescriptions have tapered off, except in the most extreme instances.

Read More

How Does the Body Get Addicted to Opioids?

Opioid overdose-related deaths have been a national concern for the past few years. In our own state of Connecticut, fatalities have tripled since 2012. Whether Fentanyl, prescription painkillers or heroin is to blame, cities that have shouldered costs related to Narcan administering and rehabilitation are now fighting back, filing lawsuits against major drug manufacturers.

Read More

Are Drug Companies & Doctors Responsible for the Opioid Crisis?

The current opioid epidemic in the United States is the worst drug crisis our country has ever seen. According to the Centers for Disease Control and Prevention (CDC), 91 Americans die each day from an overdose. Of more than 30,000 annual opioid overdose deaths, half are due to prescription drugs. Amidst this national emergency, the question has become: Who is responsible?

Read More

What Are the Details of the Xarelto Lawsuits?

This content is for informational purposes only Trantolo & Trantolo is not currently accepting cases for this lawsuit. Please check in the future for any updates.   Some prescriptions can be dangerous. Xarelto (Rivaroxaban), a popular anticoagulant manufactured by Janssen Pharmaceutical, is facing several lawsuits due to the risk of serious injury or death after…

Read More

Latest Risperdal Case Developments: New Study, Start of Bellwether Trial, $2.2 Billion Settlement

With 900 pending Multi-District Litigation cases in Philadelphia, the first bellwether trial concerning Risperdal’s side effects started on Monday. The Nov. 3 trial (Re: Risperdal Litigation, Case No: 100300296, in the Philadelphia Court of Common Pleas) is the start of three to determine how the jury will respond. The second has been scheduled for January…

Read More